Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials Article

Industry Collaboration International Collaboration

cited authors

  • Verma, Subodh; Bain, Stephen C.; Fries, Tea Monk; Mazer, C. David; Nauck, Michael A.; Pratley, Richard E.; Rasmussen, Soren; Saevereid, Hans A.; Zinman, Bernard; Buse, John B.

authors

Publication Date

  • July 1, 2019

webpage

published in

category

keywords

  • LEADER
  • SUSTAIN 6
  • cardiorenal
  • cardiovascular
  • diabetes duration
  • efficacy
  • liraglutide
  • renal
  • semaglutide

start page

  • 1745

end page

  • 1751

volume

  • 21

issue

  • 7